Amitryptiline

ApprovedSmall molecule

SSt Joseph University, Beirut, Lebanon

Amitryptiline is one of 40 small molecule programs targeting Chronic Neck Pain. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Chronic Neck PainActive, not recruiting

FibromyalgiaActive, not recruiting

Chronic Neck PainApproved

Active, not recruiting

FibromyalgiaPhase 3

Active, not recruiting

Competition

Competitive Landscape

152 competitors in Fibromyalgia

#DrugCompanyPhaseTrials

Epidiolex

Jazz Pharmaceuticals

Phase 3

1 2

Namenda

AbbVie

Phase 3

1 3

Xyrem

Jazz Pharmaceuticals

Phase 3

1 4

Lexapro

AbbVie

Phase 3

1 5

Neurontin

VViatris Specialty LLC

Phase 3

3 6

Prozac

VVitae Pharmaceuticals Inc., an Allergan affiliate

Phase 3

1 7

Ultram

WWim Janssens

Phase 3

1 8

DS-5565

Daiichi Sankyo

Phase 3

4 9

Genotropin

EMD Serono

Phase 3

—10

Feosol

AAuerbach Hematology Oncology Associates P C

Phase 3

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Chronic Neck Pain1 trial

Low Doses Amitriptyline & Chronic Neck Pain

Completed·SSt Joseph University, Beirut, Lebanon·Phase 4·NCT01561209·212 enrolled

Fibromyalgia1 trial

Anti-Depressants vs Physiotherapy in Management of Fibromyalgia

Completed·—·Phase 3·NCT00704899·175 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Amitryptiline. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Amitryptiline compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Amitryptiline. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — St Joseph University, Beirut, Lebanon company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: SSt Joseph University, Beirut, Lebanon

Amitryptiline

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Chronic Neck Pain1 trial

Fibromyalgia1 trial

References

Drug Info

Quick Facts

Related News